Professor Monica Robotin

MBBS, PhD, FRACS, MBA, M Appl Epid, M Int H
Head New Course Development and Quality Management

Email: monica.robotin@nd.edu.au
Phone: 02 8204 4462

  • Biography

    Professor Monica Robotin graduated with Honours from the School of Medicine, University of New South Wales and obtained specialist qualifications in cardio-thoracic surgery in Australia, followed by Fellowships in congenital heart surgery in France and the United States. As the first female surgeon to be awarded the Graham Traveling Fellowship by the American Association of Thoracic Surgeons, she worked at Washington University and St Louis Children’s Hospital, where she researched the mechanism of re-entry arrhythmias following paediatric cardiac surgery and developed a growing vascular graft.

    Following a career change she obtained a Master Degree in Business Administration, with sub-majors in Communication and Health Management. For her Master of Applied Epidemiology degree she conducted the first analysis of surveillance data on newly acquired hepatitis B and C infections in Australia and examined the clinical characteristics of AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapies. Her Master of International Health examined barriers to HIV voluntary counselling and testing in Mpumalanga Province (South Africa). Her PhD examined the feasibility of a population-level response to chronic hepatitis B infection in Australia.

    As Research Director of Project Support Group Southern Africa she worked in HIV – AIDS impact mitigation in South Africa. As Medical Director of Cancer Council NSW, she led a community-based program of hepatitis B education, testing and management in high risk migrant communities (B Positive). She is continuing this work through collaborations within the Sydney Health Partners consortium. As an academic at the University of Sydney, she developed new courses for the Master of Public Health program and taught in the Postgraduate Medical Program. In 2013 she spent her sabbatical leave at the Maldives National University, developing the country’s first Master of Public Health curriculum and mentoring local academics.

    She has over 80 peer-reviewed publications and co-edited two reference books and a monograph on the primary care diagnosis and management of hepatitis B infection in Australia.

    In 2016 she was appointed as Professor and Head of New Course Development and Quality Management at The University of Notre Dame Australia, School of Medicine, Sydney.

  • Teaching Areas

    Public Health and Epidemiology

  • Research Expertise and Supervision Areas

    Clinical and applied research, Public Health

  • Books

    BOOKS EDITED:

    • B Positive: all you wanted to know about hepatitis B. A guide for primary care providers. Australasian Society for HIV Medicine (ASHM), 2014, 2nd edition, 178 pp. Editors G Matthews, M Robotin, N Allard.
    • Perspectives on complementary and alternative medicine. Imperial College Press, 2012, 465 pp. Editors I Olver, M Robotin.
    • When cancer crosses disciplines. A clinician’s handbook. Imperial College Press, 2009, 1129 pp. Editors M Robotin, I Olver, A Girgis.

  • Book Chapters

    • Sheridan D, M Robotin M. Hepatitis B virus-related hepatocellular carcinoma (chapter 9, pp 93-102). In “B Positive: all you wanted to know about hepatitis B. A guide for primary care providers”. 2nd edition, 2014, ASHM. Editors G Matthews, M Robotin, N Allard.
    • Robotin M. Randomised controlled trials in the primary treatment of hepatocellular carcinoma. In “Molecular aspects of hepatocellular carcinoma” (Chapter 17, pp.174-195). Editors: L Qiao, Y Li, X Yan, J George. Bentham books 2012.
    • Robotin M. From traditional medicines to drug discovery” (chapter 8, pp 157-186). In “Perspectives on complementary and alternative medicine”. Imperial College Press, 2011. Editors I Olver, M Robotin.
    • Sundquist K, M Robotin M. What matters to patients and to carers (chapter 13, pp 317-342). In “When cancer crosses disciplines. A clinician’s handbook” 2009, Imperial College Press. Editors M Robotin, I Olver, A Girgis.

  • Journal Articles and Proceedings

    • Robotin MC, Masgoret X, Porwal M, Goldsbury D, Khoo C, George J. Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia. Clinical Epidemiology 2018 ; 10: 41—49 doi https://doi.org/10.2147/CLEP.S146275
    • Karapetis CS, Guccione L, Tattersall MHN, Gooden H, Vajdic CM, Lambert S, Robotin M, Mileshkin L, Schofield P. Perceptions of Cancer of Unknown Primary Site – A National Survey of Australian Medical Oncologists. Internal Medicine Journal. 2017 Apr;47(4):408-414. doi: 10.1111/imj.13373
    • Robotin MC, Porwal M, Hopwood M, Nguyen D, Sze M, Treloar C, George J. Listening to the consumer voice: developing multilingual cancer information resources for people affected by liver cancer. Health Expect 2017; 20: 1; 171-182 doi: 10.1111/hex. 12449
    • Robotin MC, Shaheem M, Ismail AS. Using consensus methods to develop a country-specific Master of Public Health curriculum for the Republic of Maldives. Advances in Med Educ 2016; 7: 73-80.
    • Braun L, Harris J, Katris P, Cain M, Dillon H, Koczwara B, Olver I, Robotin M. Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients. Asia-Pacific JCO 2014;10(4):289-96.2014.
    • Robotin M, George J. Community-based hepatitis B screening: what works? Hepatol Int 2014;8(4):478-92. Review. Paper featured on the MDLinx.com site- "the world's most up to date index of articles that matter in the daily lives of physicians and other healthcare professionals."
    • Robotin MC, Kansil M, Porwal M, Penman AG, George J. Community-based prevention of hepatitis B-related liver cancer: Australian insights. Bull W Health Organ 2014; 92: 374-379
    • Sitas F, Gibberd A, Kahn C, Chiew M, Supramaniam R, Velentzis L, Nickson C, Smith DP, O'Connell D, Smith MA, Armstrong K, Yu XQ, Canfell K, Robotin M, Feletto E, Penman A. Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology 2013: 37 780–787
    • Robotin M, Patton Y, George J. Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers. International Journal of General Medicine 2013:6 115–122
    • Robotin M, Patton Y, Kansil M, Penman A, George J. Cost of treating chronic hepatitis B: Comparison of current treatment guidelines. World J Gastroenterol 2012 18(42):6106-6113. doi: 10.3748/wjg.v18.i42.6106
    • Robotin M, Holliday C, Bensoussan A. Defining research priorities in Complementary Medicine in oncology. Complementary Therapies in Medicine. 2012, Vol 20 (5) pp 345- 52
    • Robotin M. Botanical products in the 21st century: from whence to whither. Cancer Forum, 2011, 35 (1)
    • Robotin M. Hepatitis B prevention and control: lessons from the East and the West. World J Hepatol 2011; 3 (2) 31-37. Editorial.
    • Robotin M. Enquiring about cancer patients' use of complementary and alternative medicines: Is our job done? Asia Pac J Clin Oncol 2010;6(4):245-7. Editorial.
    • Robotin MC, Kansil M, Howard K, George J, Tipper S, et al. Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilization. BMC Health Services Research 2010: 10:215.
    • Holliday C, Robotin M. The Delphi process: a solution for reviewing novel grant applications. International Journal of General Medicine 2010:3 1–6.
    • Robotin MC, Jones SC, Biankin AV, Waters L, Iverson D, Gooden H, et al. et al. Defining research priorities for pancreatic cancer in Australia: results of a consensus development process. Cancer Causes Control 2010;21(5):729-36 Paper featured on the MDLinx.com site- "the world's most up to date index of articles that matter in the daily lives of physicians and other healthcare professionals."
    • Saunders C, Gooden H, Robotin M, Mumford J. As the bell tolls: a foundation study on pancreatic cancer consumers' research priorities. BMC Research Notes 2009, 2:179
    • George J, Robotin M. Overview: Hepatocellular carcinoma - the future starts now. Cancer Forum 2009, 33 (2) 83-87 .Editorial.Alam N, Robotin M, Baker D. Epidemiology of primary liver cancer. Cancer Forum 2009, 33 (2) 88-92.
    • Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, et al. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. Journal of Hepatology 2009;50(5):990-998. Editorialised in the Journal of Hepatology: Sherman M. Prevention of hepatocellular carcinoma: The holy grail of hepatitis B treatment. Journal of Hepatology 2009; 50:854-856. Included in the Tufts Medical Centre Cost-Effectiveness Analysis (CEA) Registry: http://www.cearegistry.org
    • Saunders C, Robotin M, Crossing S. By invitation only - the case for breast cancer screening reminders for women over 69 years. Aust New Zealand Health Policy 2008;5 :23.
    • Chang, DK; Merrett, ND; Biankin, AV, et al. Improving outcomes for operable pancreatic cancer: Is access to safer surgery the problem? J Gastroenterology and Hepatology 2008; 23 (7) 1036-1045
    • Robotin MC, George J, Supramaniam M, et al. Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy?/IN REPLY. Awofeso N Med J Aust.2008 Aug 18; 189(4): 237.
    • Robotin M. Successful lung transplantation for adolescents at a hospital for adults. Med J Aust. 2008 Apr 7;188(7):430.
    • Robotin M, George J, Supramaniam R, Sitas F, Penman A. Preventing liver cancer: how well are faring towards of National Hepatitis B Strategy? Med J Aust. 2008 Mar 17;188(6):363-5.
    • Supramaniam R, O'Connell D, Robotin M, Tracey E, Sitas F. Future cancer trends to be influenced by past and future migration. Aust NZ J Public Health. 2008 Feb;32(1):90-2.
    • Robotin M, George J, Dore G, Tipper S, Penman A. Reducing the Incidence of Liver Cancer in Australia: what would it cost? . Australasian Epidemiologist Vol 14 (3), September 2007
    • Robotin MC, Penman A. Integrating complementary therapies into mainstream cancer care: which way forward? MJA 2006; 185 (7): 377-9.
    • Robotin MC, Law M, Milliken S, Garsia R, Goldstein D, Dolan G, Grulich A. Clinical characteristics and determinants of survival following AIDS- NHL in a population-based cohort in Sydney, Australian HIV Medicine 2004; (5): 1-8.
    • Robotin MC, Copland J, Tallis G, Coleman D, Giele C, Carter L, Spencer J, Kaldor J, Dore G. Surveillance for newly acquired hepatitis C in Australia, 1997-2001. J Gastroenterol Hepatol 2004;(19): 283-288.
    • Robotin MC, Law MG, Milliken S, et al. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia. HIV Med 2004;5(5):377-84.
    • Robotin M. Evaluation of the Australian CJD surveillance system. Commun Dis Intell. 2002; 26(2):265-72.
    • Spencer J, Dore G, Robotin M, Correll P, Kaldor J. Outcomes from the first two years of the Australian hepatitis C surveillance Strategy. Commun Dis Intell. 2002; 26(1):14-22.
    • Macdonald M, Robotin M. Drug use trends among injecting drug users: findings from the Australian Needle and Syringe Program (NSP) Survey: 1995- 2000. Illicit Drug Reporting System. October 2001.
    • Serraf A, Sellak H, Herve P, Bonnet N, Robotin MC, Detruit H, Planche C. Vascular endothelial viability and function after total cardiopulmonary bypass in neonatal piglets. Am J Respir Crit Care Med. 1999; 159(2): 544-51.
    • Robotin MC, Swanson P, Johnson DC, Schuessler R, Cox J. An experimental model of small intestinal submucosa as a growing vascular graft. J Thorac Cardiovasc Surg. 1998; 116(4): 805-11.
    • Serraf A, Robotin MC, Bonnet N, Detruit H, Baudet B, Mazmanian M, Herve P, Planche C. Alteration of the neonatal pulmonary physiology after total cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1997; 114(6): 1061-9.
    • Robotin MC, Serraf A, Houyel L, Petit J, Lacour-Gayet F, Bruniaux J, Planche C: Prevention of unbalanced lung perfusion and atrial arrhythmias by modifications of the lateral tunnel operation. Ann Thorac Surg. 1997; 64(5): 1389-95.
    • Serraf A, Lacour-Gayet F, Robotin MC, Bruniaux J, Sousa-Uva M, Roussin R, Planche C. Repair of interrupted aortic arch: a ten -year experience. J Thorac Cardiovasc Surg. 1996; 112(5): 1150-60.
    • Robotin MC, Bruniaux J, Serraf A, Uva MS, Roussin R, Lacour-Gayet F, Planche C: Unusual forms of tracheobronchial compression in infants with congenital heart disease. J Thorac Cardiovasc Surg. 1996; 112(2): 415-23.
    • Robotin MC, Edis B, Weintraub R, Pawade A, Karl T. Heart transplantation for chyloptysis after Fontan operation. Ann Thorac Surg. 1995; 59(6): 1570-1.
    • McGuire MA, Yip AS, Robotin MC, Bourke JP, Johnson DC, Dewsnap BI, Chard R, Uther JB, Ross DL. Surgical procedure for the cure of atrioventricular junctional ("AV node") reentrant tachycardia: anatomic and electrophysiologic effects of dissection of the anterior atrionodal connections in a canine model. J Am Coll Cardiol. 1994; 24(3): 784-94.
    • McGuire MA, Robotin MC, Yip AS, Bourke JP, Johnson DC, Dewsnap BI, Grant P, Uther JB, Ross DL. Electrophysiologic and histologic effects of dissection of the connections between the atrium and posterior part of the atrioventricular node. J Am Coll Cardiol. 1994; 23(3): 693-701.
    • McGuire MA, Bourke J, Robotin MC, Johnson DC, Meldrum-Hanna W, Nunn G, Uther JB, Ross DL. High resolution mapping of Koch's triangle using sixty electrodes in humans with atrioventricular junctional re-entry tachycardia. Circulation. 1993; 88(5): 2315-28.
    • McGuire MA, Johnson DC, Robotin MC, Richards D, Uther JB, Ross DL: Dimensions of the triangle of Koch in humans. Am J Cardiol. 1992; 15: 70(7) 829-830.
      Robotin MC, Chang VP, Shanahan MX, Farnsworth AE, Esmore DS, Spratt PM. Ascending aortic aneurysm associated with aortic valve regurgitation:- St. Vincent's Hospital's experience. Aust N Z J Surg. 1989; 59(8): 611-16.
    • Little JM, Robotin M: Serum bilirubin after surgery for obstructive jaundice. Aust N Z J Surg. 1986; 56(1)35-37.

  • Conference Papers

    ABSTRACTS:

    • McKee K, Robotin M, Ko A, George J. An integrated approach to viral hepatitis management in the community: tackling hepatitis B and C using a model of shared care. Australasian viral hepatitis elimination conference. Journal of Virus Eradication 2017; 3 Suppl 2, p38, p25
    • Stone K, Robotin M, Porwal M, Jacob G. Implementing a shared care model to prevent liver cancer and improve chronic hepatitis B outcomes in a high disease prevalence area. Journal of Clinical Oncology. 2015, Vol 11, Suppl 4, A203: 115.
    • Liu Y, Zhao Y, Robotin M. Can media coverage influence research article citations? Asia-Pacific Journal of Clinical Oncology. 2014, Vol 10, Suppl 8, A203.
    • Robotin M, Masgoret X, Porwal M, et al. Using a disease Registry to characterise the chronic hepatitis B epidemic in Sydney, NSW. Hepatol Int 2014;8:1S126
    • Robotin MC, Shaheem M, Ismail AS. Using consensus methods to develop a country-specific Public Health curriculum at the Maldives National University. Med Decis Making, April 2014; vol. 34, 3: pp. E1-E38.
    • Liu Y, Zhao Y, Robotin M. How is cancer research reported by the Cancer Council's Cancer Daily News. Asia-Pacific Journal of Clinical Oncology. 2013, Vol 9, Suppl 3, p 102, A148.
    • Sitas F, Gibberd A, Kahn C, Chiew M, Supramaniam R, Velentzis L, Nickson C, Smith DP, O'Connell D, Smith MA, Armstrong K, Yu XQ, Canfell K, Robotin M, Feletto E, Penman A. Changes in cancer mortality and incidence in Australia 1987-2007. Asia-Pacific Journal of Clinical Oncology. 2013, Vol 9, Suppl 3, p 131, A253.
    • Fraser A, X Masgoret X, Robotin M, Porwal M. Using hepatitis B Registry data to improve liver cancer prevention at primary care level. Asia-Pacific Journal of Clinical Oncology. 2012, Vol 8, Suppl 3, p 180, A408
    • Porwal M, Hillman B, Russell M, Robotin M. Engaging youth in reducing the burden of liver cancer in culturally and linguistically diverse communities. Asia-Pacific Journal of Clinical Oncology. 2012, Vol 8, Suppl 3, p 180, A408
    • Patton Y, Porwal M, George J, Penman AG, Robotin M. Developing a chronic hepatitis B disease registry to prevent hepatocellular carcinoma in NSW. Asia-Pacific Journal of Clinical Oncology. 2011, Vol 7, Suppl 4, p 180
    • Porwal M, Robotin M. Community based interventions raising awareness and promoting screening for chronic hepatitis B in CALD communities. Asia-Pacific Journal of Clinical Oncology. 2011, Vol 7, Suppl 4, p 187
    • Robotin M, Patton Y, Putha V, George J. Population-level prevention of hepatitis B-related HCC in Australia- the primary care perspective. Hepatology International 2011. Vol 5 Suppl1, p 465
    • Holliday C, Pigot M, Robotin M. Results of a pilot program for research volunteers. Asia-Pacific Journal of Clinical Oncology. 2010, Vol 6, Suppl 3, p 106
    • Robotin M, Holliday C, Bensoussan A. Research priorities in complementary medicine in Australia: recommendations of a consensus-building process. Asia Pacific Journal of Clinical Oncology. 2010, Vol 6, Suppl 3, p 110
    • Liu Y, Zhao Y, Robotin M. Supporting health literacy improvements in a community-based cancer control organisation: a librarian's view. Asia-Pacific Journal of Clinical Oncology. 2010, Vol 6, Suppl 3, p 172
    • Robotin M, Patton Y, Putha V, Tipper S, George J. Collaborating with general practitioners in cancer control: lessons from the B Positive Project. Asia-Pacific Journal of Clinical Oncology. 2010, Vol 6, Suppl 3, p 224
    • Robotin MC, Kansil M, Howard K et al. Moving from patient to population-level hepatitis B management in Australia. Journal of Hepatology 2010 Vol 52 PpS278-79 Suppl 1
    • Holliday C, Thomas N, Pigot M, Crossing S, Robotin M. Consumer research forum: proactively engaging consumers in research. Asia-Pacific Journal of Clinical Oncology. 2009, Vol 5, Suppl 2
    • Holliday C, Robotin M. The Delphi process: a solution for reviewing novel grant applications. Asia-Pacific Journal of Clinical Oncology. 2009, Vol 5, Suppl 2
    • Holliday C, Pigot M, Sieczko P, Robotin M. Increasing patient recruitment in a national brain tumour study. Asia-Pacific Journal of Clinical Oncology. 2009, Vol 5, Suppl 2
    • Pigot M, Holliday C, Hodgkinson V, Robotin M. Use of a volunteer workface to enhance participation in health research. Asia-Pacific Journal of Clinical Oncology. 2009, Vol 5, Suppl 2
    • Pigot M, Holliday C, Gardoll M, Mealey M, Robotin M. Identification of health research competencies to develop training for a volunteer workforce. Asia-Pacific Journal of Clinical Oncology. 2009, Vol 5, Suppl 2
    • Tipper S, Lee P, Pham NQP, Robotin M. Targeted community education through community organisations in the 'B Positive' Project: raising awareness, improving access and taking action to manage chronic hepatitis B infection and prevent liver cancer. Asia-Pacific Journal of Clinical Oncology. 2009, Vol 5, Suppl 2
    • Tipper SW, Robotin M, Zwar NA, George J. Using chronic disease management planning to optimize the management of chronic hepatitis B and prevent liver cancer. Asia-Pacific Journal of Clinical Oncology. 2009, Vol 5, Suppl 2
    • Gooden HM, Saunders C, Friedsam J, Robotin M. Recommending research priorities in pancreatic cancer: listening to the consumer voice. Asia- Pacific Journal of Clinical Oncology.2008, Vol 4, Suppl 2
    • Tipper S, Robotin M, Woodward J. Translating information into knowledge and practice: A critique of a novel cancer prevention intervention. Asia-Pacific Journal of Clinical Oncology. 2008, Vol 4, Suppl 2
    • Robotin M, Kansil M, Howard K. George J, Tipper S, Dore G, Levy M. Modeling population-based chronic hepatitis B screening and treatment to prevent cirrhosis and liver cancer among high risk populations in Australia. J Gastroenterology and Hepatology 2008; 23, Suppl 6
    • Sundquist K, Robotin M, Butow P, Lobb E. Who cares for the cancer health professional? An intervention to reduce stress and burnout. Asia-Pacific Journal of Clinical Oncology 2007; Vol 3, Suppl 2
    • Robotin M, George J, Clark I, Kansil M, Tipper S, Penman A, on behalf of the B Positive working group. Reducing the incidence of liver cancer in NSW- translating evidence into practice. Asia-Pacific Journal of Clinical Oncology; 3, Suppl 2 Nov 2007, A 82
    • Malica M, Cazzolli R, Robotin M, Biankin A, Barraclough B, Iverson D, Penman A. Setting Priorities in Australian Cancer Research. Asia-Pacific Journal of Clinical Oncology; 3, Suppl 2 Nov 2007, A79
    • Robotin M, Supramaniam R, Sitas F, O'Connell D, Penman A: Hepatocellular cancer and hepatitis B infection: is a public health response required? Asia-Pacific Journal of Clinical Oncology vol 2, Suppl2, 2006, A107
    • Robotin M, Supramaniam R, Sitas F, O'Connell D, Penman A: Reducing the incidence of stomach cancer- should we screen populations at higher risk? Asia-Pacific Journal of Clinical Oncology; 2, Suppl2 2006, p 107
    • Robotin M, Britt H, Knox S, O'Connell D, Penman A: The changing face of skin cancer management in Australian general practice. Asia-Pacific Journal of Clinical Oncology 2006; 2, Suppl2
    • Reid C, Birrel S, Robotin M et al. Gender disparities in the control of blood pressure and other risk factors in patients with existing cardiovascular disease: in family practice. Journal of hypertension 2005;23, Suppl 2.
    • Robotin MC. Australia needs to strengthen its surveillance system for newly acquired hepatitis C infections. Revista Espanola de Salud Publica 2002 Supl; 76: 50
    • McGuire MA, Robotin MC, Johnson DC, Bourke JP, Yip AS, Chard RB, Grant P, Dewsnap BI, Richards DA, Uther JB, Ross DL. Anatomical and electro-physiological effects of surgery for atrio-ventricular junctional re-entrant tachycardia. Australian and New Zealand Journal of Medicine; 1991; (4) Suppl2 (21) 54.
    • McGuire MA, Johnson DC, Robotin MC, Nunn GR, Meldrum-Hanna W, Dewsnap BI, Richards DA, Uther JB, Ross DL. High resolution mapping of the right atrial septum in patients with septal accessory pathways. Australia and New Zealand Journal of Medicine; Supplement 2 (21) 4: 54, 1991
    • McGuire MA, Johnson DC, Robotin MC, Nunn GR, Meldrum-Hanna W, Dewsnap BI, Yip AS, Uther JB, Ross DL High resolution mapping of the atrial septum in patients with septal accessory pathways. Circulation; Supplement 84 (4): II 414, 1991
    • McGuire MA, Robotin MC, Johnson DC, Bourke JP, Yip AS, Dewsnap BI, Richards DA, Uther JB, Ross DL. Anatomical and electrophysiological effects of surgery for atrio-ventricular junctional ("AV nodal") re-entrant tachycardia (AVJRT) Circulation; Supplement 84 (4): II 19, 1991

  • Professional Affiliations

    Affiliate Member: American Society of Clinical Oncology Member: Oncological Society of Australia (COSA) Council Member: American Heart Association Member:Medico-Legal Society of New South Wales Member: Australian Epidemiological Association Member: International Epidemiological Association Fellow: Royal Australasian College of Surgeons

  • Community Engagement

    Plays an active role in raising community awareness of viral hepatitis and is a regular contributor to GP and community events raising awareness of hepatitis B.
    She is or has been a member of Advisory Boards and research and Ethics Committees at Cancer Council NSW and the University of Sydney and of working groups of COSA (the Oncological Society of Australia), the NSW Cancer Institute and the Basic Sciences of Oncology Advisory Committee (BSOC).

  • Awards

    • NSW Multicultural Health Communication Award for producing the Understanding Liver Cancer’ DVD in English, Vietnamese, Cantonese and Mandarin (team award)
    • Commonwealth of Australia Endeavour Executive Award – identifying Public Health research priorities in the Maldives National University
    • Hepatitis Australia - Excellence in Viral Hepatitis Health Promotion Award for “Implementing an evidenced based community program improving the health and wellbeing of people affected by hepatitis B” (team award)
    • Graham Travelling Fellowship, the American Association of Thoracic Surgery: Electrophysiological characteristics of re-entry arrhythmias after pediatric cardiac surgery
    • Gordon Lowe prize for Obstetrics and Gynaecology, UNSW School of Medicine.